Analysts: If wellness reform fails, expect more sector mergers Information outlets report on how the fate of the health care overhaul might impact health sector mergers and biotech firms. An aging population will additional increase health spending, and [o]ne alternative will be elevated consolidation, with companies led by WellPoint Inc., the largest U pharmacological-effect.html .S. Insurer by enrollment, and Community Health Systems Inc., the biggest publicly traded hospital chain, scooping up rivals unable to ‘spread rising costs across fewer customers,’ stated Paul Keckley, of the Deloitte Center for Health Solutions . Star-Ledger/NJ.com reports that although some biotech companies, including a start-up called Soligenix, are thriving, many others in the industry are struggling.
Due to the similarity of the symptoms, differentiating patients with Alzheimer's from those with other types of dementia – or patients with Parkinsondisease from people that have other electric motor disorders – is often difficult. Related StoriesFirst hospital installs Ortho Vision AnalyzerBU researcher gets prestigious fellowship to start new project for those who have dementiaMayo Clinic's Florida campus awarded NIH grant to recognize vascular risk elements in aging and dementia Making a proper diagnosis is essential if proper treatment and medicine are to commence at an early on stage. A research team at Sahlgrenska Academy, University of Gothenburg, is definitely developing a new solution to differentiate individuals with Alzheimer's Parkinson or disease disease by analyzing a cerebrospinal liquid sample.